miR-299-3p suppresses cell progression and induces apoptosis by downregulating PAX3 in gastric cancer
Gastric cancer (GC) is ranked the fourth leading cause of cancer-related death, with an over 75% mortality rate worldwide. In recent years, miR-299-3p has been identified as a biomarker in multiple cancers, such as acute promyelocytic leukemia, thyroid cancer, and lung cancer. However, the regulator...
Saved in:
Main Authors: | Wang Zhenfen, Liu Qing, Huang Ping, Cai Guohao |
---|---|
Format: | article |
Language: | EN |
Published: |
De Gruyter
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/db7eeb1c2e1741b896d847ce81510c5f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulation of Pax7 protein levels by caspase-3 and proteasome activity in differentiating myoblasts
by: Olguín,Hugo C
Published: (2011) -
Targeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer
by: Jin L, et al.
Published: (2021) -
LncRNA LINC00483 promotes gastric cancer development through regulating MAPK1 expression by sponging miR-490-3p
by: Luo,Min, et al.
Published: (2020) -
Expression of Pax6 and Pax7 Proteins During the Central Nervous System Development in Human Embryos
by: Namm,Aimar, et al.
Published: (2020) -
The diagnostic and prognostic value of miR-92a in gastric cancer: A systematic review and meta-analysis
by: Guo Hanxu, et al.
Published: (2021)